Novartis | Company & Product Resources
Expert Exchange on Sjögren’s Disease: An Autoimmune Disease That Can Be Serious and Progressive
​
Sjögren’s disease is more than dryness, often featuring sicca symptoms. Join Teja Kapoor, MD, Adam Doré, DO, and Erin Siceloff, PA, as they explore the systemic and heterogeneous nature of this serious disease.
Expert Exchange on Sjögren’s Disease: Uncovering Systemic Disease Burden Through ESSDAI Domains
​
Discover how ESSDAI-based questions help reveal systemic involvement in Sjögren’s disease. Teja Kapoor, MD, and Adam Doré, DO, highlight key domains, including glandular, articular, cutaneous, and lymphadenopathy.
Expert Exchange on Sjögren’s Disease: Identifying Your Patients Who Are "Sicca Plus" May Help Enable Timely, Targeted Intervention With Biologic Therapy
​
Learn how the “sicca plus” framework can help identify patients with Sjögren’s disease who may be eligible for biologic therapy. Teja Kapoor, MD, Adam Doré, DO, and Erin Siceloff, PA, illustrate its use through patient cases.
Expert Exchange on Sjögren’s Disease: A B-Cell–Driven Disease With Inadequate Treatment Options
​​
Teja Kapoor, MD, and Adam Doré, DO, explore the underlying pathogenesis of Sjögren’s disease, including the critical role of B cells, and discuss unmet treatment needs.